CASE

Welcome to the Brand page for “CASE”, which is offered here for Financial analysis and research for the pharmaceutical, biopharmaceutical and biotechnology industries;commercial analytics suite;business consulting and preparation of business reports for analyzing consumer strategy, marketing, commercial profitability, business and market trends, project management, economic forecasting, business performance, contract optimization, co-pay and pricing elasticity, multi-channel sales optimization, customer segmentation, competitive leveraged intelligence, trade and consumer experience data and patient centricity for the pharmaceutical, biopharmaceutical and biotechnology industries;providing non-downloadable online software for analyzing commercial strategy, marketing, commercial profitability, business and market trends, project management, economic forecasting, business performance, contract optimization, co-pay and pricing elasticity, multi-channel sales optimization, customer segmentation, competitive leveraged intelligence, trade and consumer experience data and patient centricity for the pharmaceutical, biopharmaceutical and biotechnology industries;.

Its status is currently believed to be active. Its class is unavailable. “CASE” is believed to be currently owned by “EYGN LIMITED”.


Owner:
EYGN LIMITED
Owner Details
Description:
Financial analysis and research for the pharmaceutical, biopharmaceutical and biotechnology industries;COMMERCIAL ANALYTICS SUITE;Business consulting and preparation of business reports for analyzing consumer strategy, marketing, commercial profitability, business and market trends, project management, economic forecasting, business performance, contract optimization, co-pay and pricing elasticity, multi-channel sales optimization, customer segmentation, competitive leveraged intelligence, trade and consumer experience data and patient centricity for the pharmaceutical, biopharmaceutical and biotechnology industries;Providing non-downloadable online software for analyzing commercial strategy, marketing, commercial profitability, business and market trends, project management, economic forecasting, business performance, contract optimization, co-pay and pricing elasticity, multi-channel sales optimization, customer segmentation, competitive leveraged intelligence, trade and consumer experience data and patient centricity for the pharmaceutical, biopharmaceutical and biotechnology industries;
Categories: FINANCIAL ANALYSIS RESEARCH